News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ARYx Therapeutics, Inc. Schedules Second Quarter 2008 Results and Earnings Call
August 6, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FREMONT, Calif.--(BUSINESS WIRE)--ARYx Therapeutics Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced today that a conference call to discuss second quarter 2008 results will be held on Wednesday, August 13, 2008 at 8:00 a.m. Pacific Time.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
Biogen Upends 20 Employees After Axing AAV Work
September 30, 2025
·
207 min read
·
BioSpace Editorial Staff
Series A
Novo-Backed Crystalys Debuts With $205M to Tackle Gout
September 30, 2025
·
2 min read
·
Tristan Manalac
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
September 29, 2025
·
1 min read
·
Annalee Armstrong
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
September 29, 2025
·
4 min read
·
Annalee Armstrong